Resources

Coulter Partners successfully completed a search assignment for mOm Incubators and to place Daniel Green as Chief Operating Officer.

We’re excited to launch She Steers, NEDs in Biotech, a specialist Non-Executive Director (NED) board programme created for women across life sciences and biotech.

J.P. Morgan’s healthcare conference may be wrapped up, but it has set some tangible momentum and without doubt a more buoyant mood for global life sciences going into 2026.

PIR International recently partnered with Slingshot Therapeutics in appointing Bobby Soni as Chief Business Officer.

Coulter Partners successfully led a search assignment for Trevi Therapeutics, placing David Hastings as Chief Financial Officer (CFO).

This week JPM kicks off in San Francisco with BIA hosting a UK Reception. A significant week for BIA too with the long-awaited announcement of our new CEO.

We are delighted to announce the appointment of Professor Chris Molloy as our new Chief Executive Officer, starting in May 2026.

Amici Procurement Solutions Rebrands as MyAmici. The rebrand reflects the organization’s strategic evolution from a procurement-focused provider to a comprehensive, end-to-end LabOps platform supporting biotech, medtech, and life-science organisations across every stage of growth.

Coulter Partners completed a search assignment for Alethio Therapeutics, placing Dr. Rohit Batta as Chief Executive Officer.

Happy New Year to all our BIA members and collaborators. We hope that the break has provided an opportunity for a refresh, ready for a jam-packed 2026.

Minister for Skills Baroness Jacqui Smith chose Precision Health Technology Accelerator (PHTA) as the setting for the launch of a new Higher Technical Qualification (HTQ) designed to tackle the UK’s growing medtech skills shortage.

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, today announced a further strengthening of its senior leadership with Ian Coyne joining the Managing Partners group. In addition to this strategic leadership expansion, the firm further refined the structure of its Senior Leadership team, with Joe Coulter assuming a new role as Chief Business Officer (CBO) and Charlotte James being promoted to Chief Operating Officer (COO).

Oxford Nanopore Technologies has appointed Francis Van Parys as Chief Executive Officer (CEO). Francis will join the Company and the Board as an Executive Director on 2 March 2026.

BIA thought leadership takes centre stage with two key reports published: last week saw the release of 'From innovation to impact: unlocking patient access to innovative rare disease medicines', and today 'UK cell and gene therapy: driving efficiencies and innovation' celebrates real-world UK success.

Meet the newly elected BIA Board members bringing fresh expertise to shape the future of life sciences.

Enedra Therapeutics appoints Adrian Ibrahim, PhD, MBA, as its new Chief Executive Officer. Dr Ibrahim will also join the Company’s Board of Directors.

Just one month after launch, five early-stage science companies have moved into the Leap incubator lab space at ARC West London. The first cohort of innovators joining Leap includes: Solveteq, Reseda Life Sciences, Tachmed, IgEDAPT, and Sea2Carbon.

BioPartner UK is delighted to announce the appointment of Nathalie Huther to its Advisory Board.

NRG Therapeutics, an innovative neuroscience company targeting a novel mechanism to address mitochondrial dysfunction, is pleased to announce expansion of its team with the appointment of Paul Thompson PhD as Chief Development Officer (CDO).

Senior leaders from PHTA and Clinical Immunology Services took home the top prizes in two prestigious categories at the West Midlands Innovation Awards